EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sacubitril valsartan combined with bisoprolol reduces doxorubicin-induced cardiotoxicity in rats by attenuating oxidative stress

Ping Liu, Hui Yang, Runqi Li, Hui Huang, Min Xu

Experimental Biology and Medicine · 28.04.2026 · 251

DOI: 10.3389/ebm.2026.10946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, online erschienen am 28.04.2026. Verfasst von Ping Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Department, Xinhua Hospital of Ili Kazak Autonomous Prefecture, Yining, Xinjiang, China. Hauptthemen laut MEDLINE: Oxidative Stress, Doxorubicin, Bisoprolol, Cardiotoxicity. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin-induced cardiotoxicity remains a leading cause of mortality among cancer patients, with oxidative stress serving as a central pathogenic mechanism. This study investigated whether combination therapy with sacubitril valsartan and bisoprolol attenuates doxorubicin-induced cardiotoxicity through modulation of oxidative stress pathways. Sixty male Sprague-Dawley rats were randomized into five groups: control, doxorubicin (DOX), bisoprolol (1.0 mg/kg/d), sacubitril valsartan (30 mg/kg/d), and combination therapy. All groups except control received intraperitoneal DOX (2.5 mg/kg weekly for 5 weeks). Cardiac function was assessed by echocardiography, myocardial injury by histopathology and enzyme levels (CK-MB, cTnI, BNP), and oxidative stress by ROS fluorescence, MDA, and SOD. Protein expression of Nrf2, HO-1, and Keap1 was analyzed by Western blot. DOX administration significantly impaired cardiac function, induced myocardial structural damage, elevated cardiac enzymes and oxidative stress markers, and downregulated Nrf2 pathway proteins compared to controls (all P < 0.05). All treatment groups significantly attenuated these abnormalities versus DOX (all P < 0.05), with combination therapy demonstrating superior cardioprotection evidenced by greatest improvement in LVEF (68.74 ± 6.87% vs. 50.26 ± 6.11%, P < 0.05), lowest cardiac enzyme levels, and most robust restoration of Nrf2 pathway expression. These findings demonstrate that sacubitril valsartan combined with bisoprolol effectively reduces doxorubicin-induced cardiotoxicity in rats by activating Nrf2-mediated antioxidant responses, providing experimental evidence for a potentially synergistic prophylactic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressDoxorubicinBisoprololCardiotoxicityTetrazolesAminobutyratesAnimalsMaleRats, Sprague-DawleyDrug CombinationsRatsValsartanBiphenyl CompoundsDrug Therapy, Combination

Stichwörter der Autor:innen

adriamycinbisoprololcardiotoxicityoxidative stresssacubitril valsartan

Substanzen

DoxorubicinBisoprololDrug Combinationssacubitril and valsartan sodium hydrate drug combinationValsartanBiphenyl CompoundsTetrazolesAminobutyrates

Autor:innen und Institutionen

  • Laboratory Department, Xinhua Hospital of Ili Kazak Autonomous Prefecture, Yining, Xinjiang, China.
  • Department of Cardiology, The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, China.
  • Department of Nephrology, The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, China.
  • Department of Cardiology, Xinhua Hospital of Ili Kazak Autonomous Prefecture, Yining, Xinjiang, China.
  • Department of Critical Care Medicine, Xinhua Hospital of Ili Kazak Autonomous Prefecture, Yining, Xinjiang, China.

Zitieren

APA

Liu, P., Yang, H., Li, R., Huang, H., & Xu, M. (2026). Sacubitril valsartan combined with bisoprolol reduces doxorubicin-induced cardiotoxicity in rats by attenuating oxidative stress. Experimental Biology and Medicine, 251. https://doi.org/10.3389/ebm.2026.10946

Vancouver

Liu P, Yang H, Li R, Huang H, Xu M. Sacubitril valsartan combined with bisoprolol reduces doxorubicin-induced cardiotoxicity in rats by attenuating oxidative stress. Experimental Biology and Medicine. 2026;251. doi:10.3389/ebm.2026.10946

BibTeX
@article{Liu2026,
  author = {Liu, Ping and Yang, Hui and Li, Runqi and Huang, Hui and Xu, Min},
  title = {Sacubitril valsartan combined with bisoprolol reduces doxorubicin-induced cardiotoxicity in rats by attenuating oxidative stress},
  journal = {Experimental Biology and Medicine},
  year = {2026},
  volume = {251},
  doi = {10.3389/ebm.2026.10946}
}
Kostenlos starten →